DRE and Prostate Cancer

Friday 27th March 2020

A digital rectal examination (DRE) is a useful screening tool, which can be used in conjunction with a PSA test, to help determine if a patient should be referred on a prostate cancer pathway. Prostate cancers may not necessarily secrete PSA; and so a PSA alone may be falsely reassuring. Thus, a DRE can form an important part of the prostate cancer investigation process.

The examination:

All practitioners should be able to perform a DRE, as the prostate is positioned close to the anal vert, therefore the length of fingers do not restrict the examination. During a DRE, practitioners should assess the prostate to see if it is significantly:

Jagged
Hard
Irregular, as opposed to smooth.

 

Find out more:

Access GatewayC’s course ‘Prostate Cancer – Responding to a PSA Screening Request’ and collect up to 2 hours of CPD here.

Access this BMJ learning module here

Keep up to date: Twitter | Facebook | LinkedIn

Latest from the Blog

Cancer Keys: Sudden onset diabetes

Cancer Keys: Sudden onset diabetes

Sudden onset diabetes Symptoms of pancreatic cancer can often be vague; however sudden onset diabetes can be a potential indicator of the disease. Potential pitfall Diabetes, especially Type 2, is common among the general population. However, consideration should be...

read more
Are COPD symptoms masking a lung cancer?

Are COPD symptoms masking a lung cancer?

Lung cancer is the 3rd most common cancer in the UK, yet the most common route to diagnosis is through emergency presentation. COPD and Lung Cancer Pre-existing conditions, such as Chronic Obstructive Pulmonary Disease (COPD), can increase a person’s risk of lung...

read more

Related Posts

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.